Clinical Trial Detail

NCT ID NCT01465659
Title Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Northwestern University
Indications

islet cell tumor

Therapies

Pazopanib + Temozolomide

Age Groups: adult

No variant requirements are available.